Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-04 @ 7:25 PM
Study NCT ID:
NCT04394650
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2020-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
Sponsor:
Juno Therapeutics, a Subsidiary of Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-14
First Submit QC Date:
None
Study First Post Date:
2020-05-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-24
Last Update Post Date:
2024-07-26
Last Update Post Date Type:
ACTUAL